As per the latest report by IMARC Group, titled "GCC Minimally Invasive Surgery Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the GCC minimally invasive surgery market size reached US$ 952 Million in 2022. Minimally invasive surgery (MIS) is a medical technique that uses advanced technology to perform surgery with minimal damage to surrounding tissue. It utilizes small surgical instruments, cameras, and specialized lighting systems that allow the surgeon to visualize the surgical site through a small incision, enabling them to perform the procedure precisely and accurately. MIS offers various advantages over traditional open surgery, including smaller incisions, less pain, shorter hospital stays, faster recovery times, and fewer complications. It also provides a lower risk of infection and scarring. Some standard types of MIS include laparoscopy, endoscopy, and robotic surgery. Among these, laparoscopy involves inserting a small camera and other instruments through small incisions in the abdomen, while the equipment used in endoscopy is inserted through the mouth or anus. On the other hand, robotic surgery employs a robotic system to perform the surgery with the assistance of a surgeon. MIS is commonly used for procedures such as gallbladder removal, hernia repair, and appendectomy, among others.
GCC Minimally Invasive Surgery Market Trends:
The increasing incidence of chronic diseases, such as cancer and cardiovascular disease, represents the key factor fueling the minimally invasive surgery market in GCC. In line with this, the burgeoning population and the rising consumer awareness regarding the multiple advantages of MIS over traditional open surgeries, including cost-effectiveness, lower rates of complications, and reduced blood loss, are bolstering the market growth. Additionally, governments in the GCC region are increasingly investing in improving healthcare infrastructure. They are also organizing programs promoting the use of minimally invasive surgeries to improve patient outcomes and reduce healthcare costs, which, in turn, is creating a positive outlook for the market. Apart from this, significant technological advancements, such as the development of specialized surgical instruments, laparoscopes, and high-resolution cameras that have allowed surgeons to perform complex procedures through small incisions, are propelling the market growth. Other factors, such as burgeoning healthcare expenditure and inflating consumer expenditure power, are providing an impetus to market growth. Looking forward, the market value is projected to reach US$ 1,552 Million by 2028, expanding at a CAGR of 8.2% during 2023-2028.
- By the product type, the market is segmented into surgical devices, laparoscopy devices, and monitoring and visualization devices.
- Based on the application, the market is categorized into bariatric, breast, cardiac, cosmetic, gastrointestinal, gynaecological, orthopedics and spine, thoracic, and other surgeries.
- On the basis of the end user, the market is divided into hospitals, clinics, and others.
- By the country, the market is segregated into Saudi Arabia, the UAE, Qatar, Oman, Kuwait, and Bahrain.
- The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis
||Product Type, Application, End User, Country
||Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800